Last reviewed · How we verify
FDA approved mRNA vaccines
At a glance
| Generic name | FDA approved mRNA vaccines |
|---|---|
| Sponsor | Biomedical Advanced Research and Development Authority |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Systems Biological Analysis of Immune Responses to RSV Vaccine (PHASE4)
- Retail COVID-19 Study
- A Phase 1 Study to Assess the Safety and Immunogenicity of JCXH-221, an MRNA-based Broadly Protective COVID-19 Vaccine (PHASE1)
- Vaccine Responsiveness in Patients With Chronic Lymphocytic Leukemia
- A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
- The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: